Edition:
United States

Entegris Inc (ENTG.OQ)

ENTG.OQ on NASDAQ Stock Exchange Global Select Market

29.45USD
25 Sep 2018
Change (% chg)

$-0.75 (-2.48%)
Prev Close
$30.20
Open
$30.20
Day's High
$30.40
Day's Low
$29.45
Volume
245,719
Avg. Vol
284,442
52-wk High
$39.55
52-wk Low
$27.30

Latest Key Developments (Source: Significant Developments)

Entegris Acquires Flex Concepts Inc To Complement Bioprocess Suite
Tuesday, 26 Jun 2018 06:06pm EDT 

June 26 (Reuters) - Entegris Inc ::ENTEGRIS ACQUIRES FLEX CONCEPTS, INC. TO COMPLEMENT BIOPROCESS SUITE.NEITHER PURCHASE PRICE NOR FLEX CONCEPTS FINANCIAL RESULTS ARE MATERIAL TO ENTEGRIS OVERALL FINANCIAL STATEMENTS.  Full Article

Entegris Announces Agreement To Acquire SAES Pure Gas Business From SAES Group
Wednesday, 6 Jun 2018 06:37pm EDT 

June 6 (Reuters) - Entegris Inc ::ENTEGRIS ANNOUNCES AGREEMENT TO ACQUIRE SAES PURE GAS BUSINESS, MAKERS OF MOLECULAR GAS PURIFICATION PRODUCTS, FROM SAES GROUP.ENTEGRIS WILL PURCHASE SHARES AND ASSETS WHICH COMPRISE SAES PURE GAS BUSINESS FOR APPROXIMATELY $355 MILLION.  Full Article

Entegris Says Entered Into First Amendment To ABL Credit And Guaranty Agreement
Thursday, 1 Mar 2018 05:24pm EST 

March 1 (Reuters) - Entegris Inc ::ENTEGRIS INC SAYS ENTERED INTO FIRST AMENDMENT TO ABL CREDIT AND GUARANTY AGREEMENT DATED AS OF APRIL 30, 2014 - SEC FILING.ENTEGRIS INC SAYS FIRST AMENDMENT EXTENDS FINAL MATURITY OF ABL FACILITY FROM APRIL 30, 2019 TO MARCH 1, 2023.  Full Article

Entegris Q4 GAAP Loss Per Share $0.20
Tuesday, 6 Feb 2018 06:05am EST 

Feb 6 (Reuters) - Entegris Inc ::Q4 NON-GAAP EARNINGS PER SHARE $0.42.Q4 GAAP LOSS PER SHARE $0.20 INCLUDING ITEMS.Q4 REVENUE $350.6 MILLION.FOR Q1 ENDING MARCH 31, 2018, COMPANY EXPECTS SALES OF $355 MILLION TO $365 MILLION.FOR Q1 ENDING MARCH 31, 2018, COMPANY EXPECTS NET INCOME PER DILUTED SHARE BETWEEN $0.34 AND $0.39.ON A NON-GAAP BASIS, EPS IS EXPECTED TO RANGE FROM $0.39 TO $0.44 PER DILUTED SHARE FOR Q1 ENDING MARCH 31, 2018.Q1 EARNINGS PER SHARE VIEW $0.37, REVENUE VIEW $343.5 MILLION -- THOMSON REUTERS I/B/E/S.Q4 EARNINGS PER SHARE VIEW $0.37, REVENUE VIEW $341.5 MILLION -- THOMSON REUTERS I/B/E/S.‍FOURTH-QUARTER NET LOSS INCLUDED $66.7 MILLION RELATED TO EFFECTS OF TAX CUTS AND JOBS ACT​.  Full Article

Entegris Inc prices upsized offering of $550 mln senior unsecured notes
Thursday, 2 Nov 2017 08:33pm EDT 

Nov 2 (Reuters) - Entegris Inc ::Entegris announces pricing of $550 million upsized offering of 4.625% senior unsecured notes.Entegris inc says offering ‍was upsized from previously announced $450 million aggregate principal amount of 2026 notes​.  Full Article

Entegris announces proposed $450 million senior unsecured notes offering
Wednesday, 1 Nov 2017 04:10pm EDT 

Nov 1 (Reuters) - Entegris Inc :Entegris announces proposed $450 million senior unsecured notes offering.Entegris Inc - ‍company intends to use part of net proceeds of offering to redeem all of company's 6.000% senior unsecured notes due 2022​.  Full Article

Entegris Q3 earnings per share $0.28
Thursday, 26 Oct 2017 06:00am EDT 

Oct 26 (Reuters) - Entegris Inc :Entegris reports strong third-quarter results.Q3 non-gaap earnings per share $0.40.Q3 earnings per share $0.28.Q3 sales $345.6 million versus i/b/e/s view $334.4 million.Q3 earnings per share view $0.34 -- Thomson Reuters I/B/E/S.Sees q4 2017 non-gaap earnings per share $0.35 to $0.40.Sees q4 2017 earnings per share $0.30 to $0.35.Sees q4 2017 sales $335 million to $345 million.Q4 earnings per share view $0.32, revenue view $327.9 million -- Thomson Reuters I/B/E/S.  Full Article

Entegris initiates quarterly cash dividend
Wednesday, 18 Oct 2017 07:00am EDT 

Oct 18 (Reuters) - Entegris Inc ::Entegris initiates quarterly cash dividend.Entegris Inc - ‍approved an initial quarterly cash dividend of $0.07 per share​.  Full Article

Cellect Biotechnology - Locust Walk engaged to seek strategic licensing deals and global pharma partnerships for commercialization of Cellect's Apograft
Monday, 7 Aug 2017 07:00am EDT 

Aug 7 (Reuters) - Cellect Biotechnology Ltd :Cellect Biotechnology - Locust Walk engaged to seek strategic licensing deals and global pharma partnerships for commercialization of Cellect's Apograft.  Full Article

Entegris reports Q2 non-GAAP earnings per share $0.28
Thursday, 27 Jul 2017 06:00am EDT 

July 27 (Reuters) - Entegris Inc ::Entegris reports strong second-quarter results.Q2 non-GAAP earnings per share $0.28.Q2 sales $329 million versus I/B/E/S view $324.7 million.Q2 earnings per share view $0.30 -- Thomson Reuters I/B/E/S.Sees Q3 non-gaap earnings per share $0.30 to $0.35.Sees Q3 earnings per share $0.25 to $0.30.Sees Q3 2017 sales $325 million to $340 million.Q2 GAAP earnings per share $0.28 including items.Q3 earnings per share view $0.30, revenue view $323.7 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Entegris Reports Q1 GAAP Earnings Per Share $0.40

* ENTEGRIS REPORTS RECORD SALES AND EARNINGS IN FIRST QUARTER OF 2018